Resonance Health Limited (RHT.AX)
AUD 0.04
(-2.44%)
AUD 0.04
(-2.44%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 8.58 Million | 4.4 Million | 3.82 Million | 3.77 Million | 3.66 Million | 3.62 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 8.58 Million | 4.4 Million | 3.82 Million | 3.77 Million | 3.66 Million | 3.62 Million |
| Operating Expenses | 7.99 Million | 6.02 Million | 5.6 Million | 3.59 Million | 4.84 Million | 2.75 Million |
| Selling, General and Administrative Expenses | 7.15 Million | 3.95 Million | 3.51 Million | 2.24 Million | 3.8 Million | 1.93 Million |
| Research and Development Expenses | 835.81 Thousand | 708.25 Thousand | 716.23 Thousand | 393.92 Thousand | 152.28 Thousand | 63.17 Thousand |
| Other Expenses | - | 352.35 Thousand | 1.36 Million | 951.25 Thousand | 888.55 Thousand | 756.75 Thousand |
| Cost and Expenses | 7.99 Million | 6.02 Million | 5.6 Million | 3.59 Million | 4.84 Million | 2.75 Million |
| Operating Income | 593.95 Thousand | -1.59 Million | -1.77 Million | 188.19 Thousand | -1.17 Million | 867.08 Thousand |
| Interest Expense | - | - | 3323.00 | - | - | - |
| Income Tax Expense | -796.19 Thousand | -483.69 Thousand | -409.74 Thousand | -242.33 Thousand | -237.62 Thousand | -328.55 Thousand |
| Earnings before Tax | -626.88 Thousand | -1.26 Million | -1.55 Million | 343.52 Thousand | -952.7 Thousand | 941.67 Thousand |
| Net Income | 169.3 Thousand | -780.36 Thousand | -1.14 Million | 585.85 Thousand | -715.07 Thousand | 1.27 Million |
| Earnings Per Share Basic | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
| Earnings Per Share Diluted | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
| Weighted Average Shares Outstanding | 456.06 Million | 461.14 Million | 461.14 Million | 450.26 Million | 432.38 Million | 405.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 456.06 Million | 461.14 Million | 461.14 Million | 452.23 Million | 432.38 Million | 408.9 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -0.05 | -0.26 | -0.35 | 0.15 | -0.23 | 0.31 |
| Profit Margin | 0.02 | -0.18 | -0.30 | 0.16 | -0.19 | 0.35 |
| EBITDA | -457 Thousand | -1.18 Million | -1.34 Million | 707.68 Thousand | -839.34 Thousand | 1.11 Million |
| Earnings Before Tax Margin | 0.07 | -0.36 | -0.46 | 0.05 | -0.32 | 0.24 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.32 Million | 8.58 Million | 3.26 Million | 4.4 Million | 2.3 Million | 2.1 Million |
| Cost of Revenue | - | - | - | - | -67 Thousand | - |
| Gross Profit | 5.32 Million | 8.58 Million | 3.26 Million | 4.4 Million | 2.37 Million | 2.1 Million |
| Operating Expenses | 4.54 Million | 8.97 Million | 3.73 Million | 6.02 Million | 2.84 Million | 2.75 Million |
| Selling, General and Administrative Expenses | 4.37 Million | - | 3.2 Million | - | 2.53 Million | 2.35 Million |
| Research and Development Expenses | 170.26 Thousand | - | 531.47 Thousand | - | 310.68 Thousand | 397.56 Thousand |
| Other Expenses | - | - | - | 352.35 Thousand | - | - |
| Cost and Expenses | 4.54 Million | 9.46 Million | 3.97 Million | 6.02 Million | 3.04 Million | 2.98 Million |
| Operating Income | 774.84 Thousand | -879.47 Thousand | -712.47 Thousand | -1.59 Million | -743.37 Thousand | -881.48 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 796.19 Thousand | -796.19 Thousand | -3.00 | -483.69 Thousand | -54.98 Thousand | -428.7 Thousand |
| Earnings before Tax | -69.33 Thousand | -626.88 Thousand | -557.55 Thousand | -1.26 Million | -583.55 Thousand | -680.5 Thousand |
| Net Income | 726.85 Thousand | 169.3 Thousand | -557.55 Thousand | -780.36 Thousand | -528.56 Thousand | -251.79 Thousand |
| Earnings Per Share Basic | 0.00 | - | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | 0.00 | - | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 460.9 Million | 456.06 Million | 464.62 Million | 461.14 Million | 461.14 Million | 461.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 472.31 Million | 468.47 Million | 464.62 Million | 461.14 Million | 461.14 Million | 461.14 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.03 | 1.00 |
| EBIT Margin | 0.01 | - | -0.14 | - | -0.23 | -0.31 |
| Profit Margin | 0.14 | 0.02 | -0.17 | -0.18 | -0.23 | -0.12 |
| EBITDA | 58.72 Thousand | - | -469.78 Thousand | - | -538.48 Thousand | -650.02 Thousand |
| Earnings Before Tax Margin | 0.15 | -0.10 | -0.22 | -0.36 | -0.32 | -0.42 |
PECOS
473370
082270
2381
7086
NLLSY